Study guide
9.2 MNT for Renal Diseases (AKI, CKD Stages 1-5, Dialysis, and Nephrotic Syndrome)
Nutritionist-Dietitian Licensure Examination NDLE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Licensure Law, Ethics, and the Clinical Nutritionist-Dietitian
1.1 NDLE Format, Scoring Rules, and RA 10862 Licensure Requirements 1.2 Scope of Practice, Professional Ethics, and Discipline under RA 10862 1.3 Role of the Clinical Nutritionist-Dietitian, Diet Orders, and Standard Hospital Diets
2 Chapter 2: Anatomy and Physiology for Nutrition I
2.1 Cells, Tissues, Membranes, and the Immune and Lymphatic Systems 2.2 The Digestive System: Organs, Enzymes, GI Hormones, and the Liver 2.3 Endocrine and Nervous System Regulation of Metabolism and Appetite
3 Chapter 3: Anatomy and Physiology II, Energy, and Carbohydrate Metabolism
3.1 Cardiovascular, Respiratory, Renal, Musculoskeletal, and Reproductive Systems 3.2 Energy Metabolism and Energy Expenditure Calculations 3.3 Carbohydrate Chemistry, Digestion, and Glycemic Pathways
4 Chapter 4: Protein, Lipid, Mineral, and Fluid Biochemistry
4.1 Protein Chemistry, Amino Acid Metabolism, and Nitrogen Balance 4.2 Lipid Metabolism, Lipoproteins, and Cardiovascular Biomarkers 4.3 Minerals, Water, Electrolytes, and Acid-Base Balance
5 Chapter 5: Basic Nutrition: Vitamins, Minerals, and the PDRI
5.1 Vitamin Biochemistry: Coenzyme Functions and Deficiency Syndromes 5.2 Vitamins and Minerals: PDRI Values, Food Sources, Bioavailability, Stability, and Toxicity 5.3 Philippine Dietary Reference Intakes (PDRI 2015), Pinggang Pinoy, and Dietary Guidelines
6 Chapter 6: Diet Computation and Clinical Nutrition Assessment
6.1 Food Exchange Lists, Meal Plan Computation, Food Labels, and Nutrient Density 6.2 Computing Desirable Body Weight, Total Energy Requirement, and the Diet Prescription 6.3 ABCD Methods of Clinical Nutrition Assessment
7 Chapter 7: Nutrition Diagnosis, Life-Stage Assessment, and Laboratory Data
7.1 Nutrition Diagnosis, PES Statements, and Medical Record Documentation 7.2 Pediatric, Obstetric, and Geriatric Clinical Nutritional Assessment 7.3 Interpreting Biochemical and Laboratory Data in Nutrition Assessment
8 Chapter 8: Drug-Nutrient Interactions, Diabetes, and Weight Disorders
8.1 Drug-Nutrient Interactions and Nutrient Depletion 8.2 MNT for Diabetes Mellitus and Endocrine Disorders 8.3 MNT for Overweight, Obesity, and Underweight
9 Chapter 9: MNT for Cardiovascular, Renal, and Gastrointestinal Disease
9.1 MNT for Cardiovascular Disease, Hypertension, and Dyslipidemia 9.2 MNT for Renal Diseases (AKI, CKD Stages 1-5, Dialysis, and Nephrotic Syndrome) 9.3 MNT for Disorders of the Gastrointestinal Tract
10 Chapter 10: MNT for Liver, Infectious, Respiratory, Allergic, and Neurologic Conditions
10.1 MNT for Liver, Gallbladder, and Pancreatic Disorders 10.2 MNT for Fevers, Infections, Diarrheal Disease, and Respiratory Disorders 10.3 MNT for Food Allergy and Intolerance, Skin, Rheumatic, Musculoskeletal, and Neurologic Disorders
11 Chapter 11: Critical Illness, Oncology, HIV, and Protein-Energy Malnutrition
11.1 MNT in Critical Illness, Sepsis, Trauma, and Burns 11.2 MNT in Oncology: Cancer Cachexia and Treatment Side Effects 11.3 MNT for HIV/AIDS and for Protein-Energy Malnutrition in Children and Adults
12 Chapter 12: Metabolic Disorders, Dysphagia, and Enteral Nutrition
12.1 MNT for Inborn Errors of Metabolism and Eating Disorders 12.2 Dysphagia, IDDSI Texture-Modified Diets, and Adaptive Feeding 12.3 Enteral Nutrition: Indications, Formula Selection, Access Routes, and Complications
13 Chapter 13: Parenteral Nutrition, Refeeding, and Nutrition Counseling
13.1 Parenteral Nutrition: Indications, Access, Substrates, and Compounding 13.2 Refeeding Syndrome and Complications of Parenteral Nutrition 13.3 Nutrition Counseling and Behavior Change Theories
14 Chapter 14: Nutrition Updates: Supplements, Diet Trends, and Sports Nutrition
14.1 Dietary Supplements, Herbal Medicines, and Functional Foods 14.2 Vegetarian Diets, Protein Complementation, and Popular Diet Trends 14.3 Sports Nutrition and Workplace Wellness Programs
15 Chapter 15: Community Nutrition and Population Assessment
15.1 Community Nutrition Principles, the ND's Roles, and the Philippine Health Delivery System 15.2 Nutritional Epidemiology and Health Status Indicators in the Philippines 15.3 Assessment of Community Nutritional Status and Operation Timbang Plus (OPT+)
16 Chapter 16: Dietary Surveys, Nutrition Research, and Surveillance
16.1 Food Consumption Surveys, Biochemical Tests in Surveys, and Clinical Signs of Deficiency 16.2 Food and Nutrition Research Methods, Sampling, Sample Size, and Research Ethics 16.3 National Nutrition Surveys, Demographic Data, and Designing a Nutrition Surveillance System
17 Chapter 17: Nutrition Education and Program Evaluation
17.1 Nutrition Education: Definition, Principles of Learning, Methods, and Teaching Aids 17.2 Designing a Nutrition Education Program and Measuring Customer Satisfaction 17.3 Program Planning Cycle, SMART Objectives, and Types of Evaluation
18 Chapter 18: Program Planning, Interventions, and Food Security
18.1 Nutrition Program Planning: Needs, Priorities, Constraints, Goals, and Using Evaluation Results 18.2 Nutrition Interventions and Programs for Specific Population Groups 18.3 Food and Nutrition Security, Dietary Diversity, and Vulnerable Populations
19 Chapter 19: Nutrition Governance, Networking, and Program History
19.1 National Nutrition Council (NNC) Structure and Philippine Plan of Action for Nutrition (PPAN) 19.2 Nutrition Agencies, Networking, Community Linkages, Teamwork, and Nutrition Legislation 19.3 Development of Philippine Nutrition Programs and the Country's Nutrition Problems
20 Chapter 20: Fortification, Feeding, and First 1,000 Days Laws
20.1 Food Fortification (RA 8976), Salt Iodization (RA 8172), and the 2024 Salt Industry Law 20.2 Supplementary Feeding Programs (RA 11037) and DSWD/DepEd Interventions 20.3 First 1,000 Days Law (RA 11148) and Maternal-Child Interventions
21 Chapter 21: Nutrition in the Life Cycle I
21.1 Infant and Young Child Feeding (IYCF), Philippine Milk Code (EO 51), and RA 10028 21.2 Nutrition in Pregnancy and Lactation: Physiology, Needs, Meal Patterns, and Problems 21.3 Nutrition from Infancy to School Age: Growth, Feeding Patterns, Problems, and School Programs
22 Chapter 22: Nutrition in the Life Cycle II
22.1 Nutrition for Adolescents and Adults: Growth Spurt, Risk Factors, and NCD Prevention 22.2 Nutrition for Older Adults: Aging Changes, Needs, Problems, and Senior Citizen Programs
23 Chapter 23: Food Science and Plant Foods
23.1 Chemistry of Starches, Proteins, Lipids, and Emulsions in Cooking 23.2 Food Pigments, Flavor Chemistry, and Browning Reactions (Maillard & Enzymatic) 23.3 Fruits, Vegetables, and Legumes: Classification, Market Forms, Quality, Storage, and Cookery
24 Chapter 24: Animal Foods, Cereals and Baking, and Cooking Methods
24.1 Meat, Poultry, Fish, Eggs, and Milk: Structure, Quality, Storage, and Cookery 24.2 Cereals, Flour Mixtures and Baking, Sugar Cookery, Fats and Oils, and Beverages 24.3 Heat Transfer, Dry-Heat and Moist-Heat Cooking Methods, and Filipino Cooking Techniques
25 Chapter 25: Culinary Skills, Family Meal Planning, and Food Quality
25.1 Culinary Vocabulary, Knife Cuts, Basic Sauces, and Accurate Measurement 25.2 Meal Planning for the Family, Food Budgeting, and Recipe Development 25.3 Sensory Evaluation, Objective Food Tests, and Quality Assurance in Food Production
26 Chapter 26: Food Microbiology, Preservation, and Food Law
26.1 Foodborne Pathogens, Microbial Kinetics, and FAT TOM Parameters 26.2 Food Preservation Methods, Thermal Processing, and Packaging 26.3 Philippine Food Laws, Regulatory Agencies, and Food Labeling
27 Chapter 27: Sanitation, HACCP, Waste, and Workplace Safety
27.1 Sanitation Standard Operating Procedures (SSOP) and Good Manufacturing Practices (GMP) 27.2 HACCP Principles and Critical Control Point Management in Food Service 27.3 Waste Management, Pest Control Regulation, and Occupational Safety in Food Service
28 Chapter 28: Food Service Systems, Production Planning, and Menus
28.1 Types of Food Service Delivery Systems (Conventional, Ready-Prepared, Commissary, Assembly) 28.2 Forecasting, Production Planning, and Quantity Food Production Techniques 28.3 Institutional Menu Planning, Modified Diets, and Recipe Standardization
29 Chapter 29: Distribution, Purchasing, and Storage
29.1 Food Distribution and Service Systems in Hospitals and Other Institutions 29.2 Food Purchasing Methods, Specifications, and Receiving 29.3 Storage Management, Inventory Control, and Valuation
30 Chapter 30: Cost Control, Financial Management, and Facility Layout
30.1 Food Cost Accounting, Yield Testing, and Portion Control Formulas 30.2 Menu Pricing Models, Break-Even Analysis, and Financial Statements 30.3 Food Service Facility Layout, Equipment Selection, and Workflow Ergonomics
31 Chapter 31: Equipment, Management, and Human Resources
31.1 Food Service Equipment: Selection, Capacity, Life-Cycle Cost, Depreciation, and Maintenance 31.2 Management Functions, Theories, Leadership Styles, and Managing Change in Food Service 31.3 Human Resource Management: Job Design, Recruitment, Training, Appraisal, and Discipline
32 Chapter 32: Labor Law, Permits, and Food Service Marketing
32.1 Philippine Labor Laws and Business Permits for Food Service Operations 32.2 Food Service Marketing, Menu Engineering, and Sustainable Food Service
9.2 MNT for Renal Diseases (AKI, CKD Stages 1-5, Dialysis, and Nephrotic Syndrome)
Key Takeaways Explain This Topic AI
Non-dialysis dependent CKD (Stages 3–5) mandates a controlled protein restriction of 0.6 – 0.8 g/kg/day 0.6–0.8\text{ g/kg/day} 0.6–0.8 g/kg/day ( ≥ 50 % \ge 50\% ≥ 50% high biological value) and adequate energy ( 30 – 35 kcal/kg/day 30–35\text{ kcal/kg/day} 30–35 kcal/kg/day ) to slow GFR decline and suppress uremic toxin generation.
Maintenance dialysis raises protein needs because amino acids and protein are lost into the dialysate: 1.0-1.2 g/kg/day in the 2020 KDOQI update (older guidance: 1.2 g/kg for hemodialysis and 1.2-1.3 g/kg for peritoneal dialysis).
Peritoneal dialysis dialysate contains dextrose (1.5%, 2.5%, 4.25%) contributing 300 – 800 kcal/day 300–800\text{ kcal/day} 300–800 kcal/day via systemic absorption, which must be quantified and subtracted from the oral caloric prescription.
In nephrotic syndrome, high-protein diets ( > 1.2 g/kg/day > 1.2\text{ g/kg/day} > 1.2 g/kg/day ) are strictly contraindicated because they accelerate intraglomerular hypertension and proteinuria; moderate protein intake ( 0.8 – 1.0 g/kg/day 0.8–1.0\text{ g/kg/day} 0.8–1.0 g/kg/day ) with sodium restriction ( 1.5 – 2.0 g/day 1.5–2.0\text{ g/day} 1.5–2.0 g/day ) is standard.
Calcium oxalate nephrolithiasis requires maintaining adequate dietary calcium ( 1,000 – 1,200 mg/day 1{,}000–1{,}200\text{ mg/day} 1 , 000–1 , 200 mg/day ) with meals to bind intestinal oxalate, while uric acid stones require urine alkalinization ( pH 6.5 – 7.0 \text{pH } 6.5–7.0 pH 6.5–7.0 ) and dietary purine reduction.
Last updated: October 2026
The kidneys maintain systemic homeostasis through the excretion of metabolic waste products, regulation of extracellular fluid volume and osmolality, maintenance of electrolyte and acid-base equilibrium, and secretion of essential hormones (erythropoietin, 1,25-dihydroxycholecalciferol / calcitriol, and renin). When renal functional mass declines, accumulation of nitrogenous waste (uremic toxins), hyperphosphatemia, hyperkalemia, secondary hyperparathyroidism, and fluid overload develop. Medical Nutrition Therapy is vital across all stages of renal disease to preserve residual nephron mass, prevent protein-energy wasting (PEW), and normalize biochemical parameters.
Renal Anatomy, Glomerular Filtration, and KDIGO CKD Staging
The functional unit of the kidney is the nephron , comprising the glomerulus (a high-pressure capillary network specialized for ultrafiltration) and a specialized tubular system (proximal convoluted tubule, loop of Henle, distal convoluted tubule, and collecting duct). The Glomerular Filtration Rate (GFR) expresses the volume of fluid filtered from the glomerular capillaries into Bowman's capsule per unit time and serves as the clinical index of functioning renal mass.
KDIGO Staging of Chronic Kidney Disease (CKD)
Under the Kidney Disease: Improving Global Outcomes (KDIGO) and National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF KDOQI) guidelines, CKD is defined as abnormalities of kidney structure or function persisting for > 3 months > 3\text{ months} > 3 months :
CKD Stage GFR Category GFR Range ( mL/min/1.73 m 2 \text{mL/min/1.73 m}^2 mL/min/1.73 m 2 ) Clinical Description & Primary Nutritional Focus
Stage 1 G1 ≥ 90 \ge 90 ≥ 90 Kidney damage with normal or elevated GFR; screening, blood pressure and glycemic control
Stage 2 G2 60 − 89 60 - 89 60 − 89 Mild reduction in GFR with structural/urinary damage; cardiovascular risk reduction
Stage 3a G3a 45 − 59 45 - 59 45 − 59 Mild-to-moderate GFR decline; initiate controlled protein monitoring, sodium restriction
Stage 3b G3b 30 − 44 30 - 44 30 − 44 Moderate-to-severe GFR decline; restrict protein to 0.6 − 0.8 g/kg 0.6 - 0.8\text{ g/kg} 0.6 − 0.8 g/kg , manage phosphorus
Stage 4 G4 15 − 29 15 - 29 15 − 29 Severe GFR decline; strict protein and mineral management; prepare for dialysis/transplant access
Stage 5 G5 < 15 < 15 < 15 Kidney Failure / End-Stage Renal Disease (ESRD); initiation of hemodialysis, peritoneal dialysis, or transplant
MNT for Non-Dialysis Dependent Chronic Kidney Disease (Stages 3–5)
In pre-dialysis CKD, medical nutrition therapy seeks to retard the progression of renal failure, suppress the accumulation of uremic retention solutes (urea, guanidines, indoxyl sulfate, p-cresyl sulfate), and prevent protein-energy wasting:
1. Dietary Protein Prescription
Target: 0.6 − 0.8 g/kg/day 0.6 - 0.8\text{ g/kg/day} 0.6 − 0.8 g/kg/day of dry/edema-free body weight (or 0.55 − 0.60 g/kg/day 0.55 - 0.60\text{ g/kg/day} 0.55 − 0.60 g/kg/day in metabolically stable, non-diabetic clients closely monitored by an RND).
Protein Quality: At least 50% to 60% of total protein must be of High Biological Value (HBV) (eggs, poultry, fish, meat, dairy) to supply all essential amino acids while minimizing unnecessary non-essential nitrogen.
Pathophysiological Rationale: High dietary protein intake induces vasodilation of the afferent glomerular arteriole, driving intraglomerular hypertension, capillary hyperfiltration, and accelerated glomerulosclerosis. Restricting protein reduces intraglomerular hydrostatic pressure, lowers proteinuria, and reduces hepatic production of nitrogenous uremic toxins.
2. Energy Requirements
Target: 30 − 35 kcal/kg/day 30 - 35\text{ kcal/kg/day} 30 − 35 kcal/kg/day ( 35 kcal/kg/day 35\text{ kcal/kg/day} 35 kcal/kg/day for individuals < 60 years < 60\text{ years} < 60 years ; 30 kcal/kg/day 30\text{ kcal/kg/day} 30 kcal/kg/day for adults ≥ 60 years \ge 60\text{ years} ≥ 60 years or sedentary).
Clinical Rule: Providing adequate non-protein calories from complex carbohydrates and healthy unsaturated fats is mandatory. If energy intake falls below 30 kcal/kg/day 30\text{ kcal/kg/day} 30 kcal/kg/day , endogenous somatic muscle is catabolized for energy, generating a spike in nitrogenous waste, worsening azotemia, and causing negative nitrogen balance.
3. Sodium and Fluid Balance
Sodium: 1.5 − 2.3 g/day 1.5 - 2.3\text{ g/day} 1.5 − 2.3 g/day ( < 100 mmol/day < 100\text{ mmol/day} < 100 mmol/day or approx. < 5.8 g NaCl < 5.8\text{ g NaCl} < 5.8 g NaCl ) to optimize blood pressure control and prevent extracellular volume expansion.
Fluid: Unrestricted in Stages 1–3 if 24-hour urine output remains normal. In Stages 4–5 with oliguria or peripheral edema, restrict to 500 − 800 mL/day + 24-hour urine output 500 - 800\text{ mL/day} + \text{24-hour urine output} 500 − 800 mL/day + 24-hour urine output .
4. Potassium Management
Target: Usually unrestricted ( > 4,000 mg/day > 4{,}000\text{ mg/day} > 4 , 000 mg/day ) in Stages 1–3 unless serum potassium exceeds 5.0 mEq/L 5.0\text{ mEq/L} 5.0 mEq/L . In Stages 4–5, restrict to 2.0 − 3.0 g/day 2.0 - 3.0\text{ g/day} 2.0 − 3.0 g/day ( 50 − 75 mEq/day 50 - 75\text{ mEq/day} 50 − 75 mEq/day ) to prevent lethal cardiac arrhythmias.
Dietary Strategies: Limit high-potassium fruits and vegetables (bananas, oranges, cantaloupe, dried fruits, potatoes, tomatoes, squash, spinach). Teach leaching techniques for tubers: peel, dice thinly, soak in large volumes of warm water for 2–4 hours, drain, and boil in fresh water.
5. Phosphorus and Calcium Equilibrium
Phosphorus Target: 800 − 1,000 mg/day 800 - 1{,}000\text{ mg/day} 800 − 1 , 000 mg/day (or < 10 − 12 mg phosphorus per gram of dietary protein < 10 - 12\text{ mg phosphorus per gram of dietary protein} < 10 − 12 mg phosphorus per gram of dietary protein ) when serum phosphorus or intact parathyroid hormone (iPTH) is elevated.
Inorganic vs. Organic Phosphorus: Emphasize the elimination of processed foods containing inorganic phosphate additives (e.g., sodium tripolyphosphate, phosphoric acid in colas, canned meats, processed cheeses). Inorganic phosphate salts have an intestinal absorption rate of 90% to 100% , compared to organic plant phosphorus (phytates, 20% to 40% absorbed) and animal phosphorus (40% to 60% absorbed).
Phosphate Binders: Calcium acetate, calcium carbonate, sevelamer hydrochloride/carbonate, lanthanum carbonate. Clinical Practice Rule: Phosphate binders must be ingested with meals and snacks to bind dietary phosphorus within the gastrointestinal lumen and prevent absorption.
Calcium: Total elemental calcium (dietary intake plus calcium-based binders) must not exceed 800 − 1,000 mg/day 800 - 1{,}000\text{ mg/day} 800 − 1 , 000 mg/day to prevent extraskeletal metastatic vascular calcification.
Maintenance Hemodialysis (HD) vs. Peritoneal Dialysis (PD)
Upon initiation of maintenance dialysis, the clinical dietetic paradigm undergoes a dramatic shift. While pre-dialysis care requires protein restriction, maintenance dialysis requires a high-protein diet due to continuous amino acid and protein clearance into the dialysate:
Nutritional Parameter Hemodialysis (HD) Peritoneal Dialysis (PD) Clinical & Physiological Rationale
Protein 1.2 g/kg/day 1.2\text{ g/kg/day} 1.2 g/kg/day ( ≥ 50 % \ge 50\% ≥ 50% HBV) 1.2 − 1.4 g/kg/day 1.2 - 1.4\text{ g/kg/day} 1.2 − 1.4 g/kg/day ( ≥ 50 % \ge 50\% ≥ 50% HBV) Dialysate losses: 10 − 12 g amino acids/session 10 - 12\text{ g amino acids/session} 10 − 12 g amino acids/session in HD; 5 − 15 g protein/day 5 - 15\text{ g protein/day} 5 − 15 g protein/day in PD. Protein loss in PD surges during episodes of peritonitis.
Energy 30 − 35 kcal/kg/day 30 - 35\text{ kcal/kg/day} 30 − 35 kcal/kg/day 30 − 35 kcal/kg/day 30 - 35\text{ kcal/kg/day} 30 − 35 kcal/kg/day (including dialysate dextrose) In PD, systemic dextrose absorption from the peritoneal dialysate supplies 300 to 800 kcal/day. Oral caloric prescription must be reduced accordingly to prevent obesity and hypertriglyceridemia.
Sodium 1.5 − 2.0 g/day 1.5 - 2.0\text{ g/day} 1.5 − 2.0 g/day ( 65 − 87 mEq 65 - 87\text{ mEq} 65 − 87 mEq ) 1.5 − 2.5 g/day 1.5 - 2.5\text{ g/day} 1.5 − 2.5 g/day ( 65 − 109 mEq 65 - 109\text{ mEq} 65 − 109 mEq ) Minimizes excessive thirst and prevents dangerous interdialytic fluid accumulation.
Fluid 500 − 1,000 mL/day + urine output 500 - 1{,}000\text{ mL/day} + \text{urine output} 500 − 1 , 000 mL/day + urine output Individualized (often 1.5 − 2.0 L/day 1.5 - 2.0\text{ L/day} 1.5 − 2.0 L/day ) HD patients are frequently anuric. Interdialytic weight gain (IDWG) between hemodialysis sessions should not exceed < 4 − 5 % < 4 - 5\% < 4 − 5% of dry body weight (or < 1.5 − 2.0 kg < 1.5 - 2.0\text{ kg} < 1.5 − 2.0 kg ).
Potassium 2.0 − 3.0 g/day 2.0 - 3.0\text{ g/day} 2.0 − 3.0 g/day ( 2 − 3 g/day 2 - 3\text{ g/day} 2 − 3 g/day ) Liberalized: 3.0 − 4.0 g/day 3.0 - 4.0\text{ g/day} 3.0 − 4.0 g/day (Unrestricted) HD removes potassium intermittently (3 times/week). PD provides continuous daily potassium removal; hypokalemia is common, requiring potassium liberalization or supplementation.
Phosphorus 800 − 1,000 mg/day 800 - 1{,}000\text{ mg/day} 800 − 1 , 000 mg/day with binders 800 − 1,000 mg/day 800 - 1{,}000\text{ mg/day} 800 − 1 , 000 mg/day with binders Neither HD nor PD clears sufficient phosphorus to prevent hyperphosphatemia and secondary hyperparathyroidism.
Note
The 2020 KDOQI nutrition guideline update recommends 0.55-0.60 g protein/kg/day (or 0.28-0.43 g/kg/day with keto-acid analogs) for metabolically stable adults with CKD stages 3-5 who are not on dialysis and do not have diabetes, 0.6-0.8 g/kg/day for those with diabetes, 1.0-1.2 g/kg/day for maintenance hemodialysis or peritoneal dialysis, and 25-35 kcal/kg/day of energy. Older figures (1.2 g/kg for hemodialysis and 1.2-1.3 g/kg for peritoneal dialysis) still appear in many reviewers, so read the standard a question cites.
Peritoneal Dialysate Dextrose Caloric Absorption Algorithm
Peritoneal dialysis solutions contain dextrose (1.5%, 2.5%, or 4.25%) as the osmotic agent. On average, 60% to 70% of the instilled dextrose is absorbed across the peritoneal membrane into the systemic circulation. Because commercial dialysate utilizes hydrous dextrose ( 3.4 kcal/g 3.4\text{ kcal/g} 3.4 kcal/g ):
Total Dextrose Instilled (g) = Total Dialysate Volume (L) × [ Concentration (g/dL) × 10 ] \text{Total Dextrose Instilled (g)} = \text{Total Dialysate Volume (L)} \times [\text{Concentration (g/dL)} \times 10] Total Dextrose Instilled (g) = Total Dialysate Volume (L) × [ Concentration (g/dL) × 10 ] Dextrose Absorbed (g) = Total Instilled (g) × 0.65 \text{Dextrose Absorbed (g)} = \text{Total Instilled (g)} \times 0.65 Dextrose Absorbed (g) = Total Instilled (g) × 0.65 Daily Energy from Dialysate (kcal) = Dextrose Absorbed (g) × 3.4 kcal/g \text{Daily Energy from Dialysate (kcal)} = \text{Dextrose Absorbed (g)} \times 3.4\text{ kcal/g} Daily Energy from Dialysate (kcal) = Dextrose Absorbed (g) × 3.4 kcal/g
Target Oral Caloric Intake = Total Estimated Energy Needs − Dialysate Calories \text{Target Oral Caloric Intake} = \text{Total Estimated Energy Needs} - \text{Dialysate Calories} Target Oral Caloric Intake = Total Estimated Energy Needs − Dialysate Calories
Acute Kidney Injury (AKI)
AKI is characterized by an abrupt decline in GFR (over hours to days) resulting in retention of nitrogenous waste and dysregulation of extracellular volume and electrolytes:
1. Etiological Classification
Prerenal Azotemia: Renal hypoperfusion without structural parenchymal damage (hypovolemia, hemorrhage, septic vasodilation, decompensated heart failure). Characterized by a BUN : Serum Creatinine ratio > 20 : 1 \text{BUN}:\text{Serum Creatinine ratio} > 20:1 BUN : Serum Creatinine ratio > 20 : 1 and Fractional Excretion of Sodium ( FeNa \text{FeNa} FeNa ) < 1 % < 1\% < 1% .
Intrinsic (Renal) AKI: Direct structural damage to glomerular, tubular, or interstitial tissue (Acute Tubular Necrosis [ATN] from prolonged ischemia or nephrotoxins like aminoglycosides and radiocontrast; acute glomerulonephritis). BUN : Cr ratio 10 − 15 : 1 \text{BUN}:\text{Cr ratio} 10 - 15:1 BUN : Cr ratio 10 − 15 : 1 ; FeNa > 2 % \text{FeNa} > 2\% FeNa > 2% .
Postrenal AKI: Mechanical urinary tract obstruction distal to the kidney (prostatic hyperplasia, bilateral ureteral calculi, retroperitoneal tumor).
2. Clinical Phases
Oliguric Phase: Urine output < 400 − 500 mL/day < 400 - 500\text{ mL/day} < 400 − 500 mL/day . Characterized by rapid azotemia, severe metabolic acidosis, hyperkalemia, hyperphosphatemia, and fluid retention.
Diuretic Phase: Urine output surges to > 1 − 3 L/day > 1 - 3\text{ L/day} > 1 − 3 L/day as tubular flow is restored while tubular epithelial concentrating ability remains impaired. Patients are at severe risk of hypovolemic dehydration, hypokalemia , and hyponatremia , requiring aggressive fluid and electrolyte repletion.
3. Protein Staging in AKI
Non-catabolic, non-dialyzed AKI: 0.8 − 1.0 g/kg/day 0.8 - 1.0\text{ g/kg/day} 0.8 − 1.0 g/kg/day .
Moderately catabolic and/or intermittent HD: 1.2 − 1.5 g/kg/day 1.2 - 1.5\text{ g/kg/day} 1.2 − 1.5 g/kg/day .
Critically ill, hypercatabolic on Continuous Renal Replacement Therapy (CRRT): 1.5 − 2.0 g/kg/day 1.5 - 2.0\text{ g/kg/day} 1.5 − 2.0 g/kg/day (up to 2.5 g/kg/day 2.5\text{ g/kg/day} 2.5 g/kg/day in massive trauma or burns) to offset dialytic amino acid clearance and sustain somatic protein synthesis.
Nephrotic Syndrome
Nephrotic syndrome is caused by increased glomerular capillary permeability to plasma proteins due to damage to podocyte foot processes and the glomerular basement membrane:
Pathognomonic Tetrad:
Massive Proteinuria: > 3.5 g / 24 hours > 3.5\text{ g / 24 hours} > 3.5 g / 24 hours (or > 50 mg/kg/day > 50\text{ mg/kg/day} > 50 mg/kg/day in pediatric patients).
Hypoalbuminemia: Serum albumin < 3.0 g/dL < 3.0\text{ g/dL} < 3.0 g/dL (frequently < 2.0 g/dL < 2.0\text{ g/dL} < 2.0 g/dL ).
Generalized Edema (Anasarca): Decreased intravascular oncotic pressure shifts fluid into the interstitial space.
Hyperlipidemia: Total cholesterol > 250 mg/dL > 250\text{ mg/dL} > 250 mg/dL , elevated LDL and VLDL. Hypoalbuminemia stimulates compensatory hepatic protein synthesis, unselectively upregulating hepatic synthesis of apolipoproteins while peripheral lipoprotein lipase (LPL) activity is suppressed.
Important
Clinical Board Exam Rule on Protein in Nephrotic Syndrome: Historically, clinicians prescribed high-protein diets ( > 1.5 g/kg/day > 1.5\text{ g/kg/day} > 1.5 g/kg/day ) to replace urinary protein loss. High-protein diets are strictly contraindicated in nephrotic syndrome. Clinical trials confirm that high-protein feeding increases intraglomerular capillary hydrostatic pressure and accelerates urinary albumin excretion without raising circulating serum albumin concentrations, directly accelerating glomerulosclerosis. The evidence-based prescription is a moderate protein diet: 0.8 − 1.0 g/kg/day 0.8 - 1.0\text{ g/kg/day} 0.8 − 1.0 g/kg/day (with at least 50% HBV).
Sodium: Restrict to 1.5 − 2.0 g/day 1.5 - 2.0\text{ g/day} 1.5 − 2.0 g/day ( 65 − 87 mEq/day 65 - 87\text{ mEq/day} 65 − 87 mEq/day ) to manage generalized peripheral edema.
Lipid Management: Saturated fat < 7 % < 7\% < 7% , elimination of trans fats, dietary cholesterol < 200 mg/day < 200\text{ mg/day} < 200 mg/day .
- Medical Nutrition Therapy for Nephrolithiasis (Renal Calculi)
- 1. Calcium Oxalate Stones (75% to 80% of all calculi)
Adequate Dietary Calcium Intake ( 1,000 − 1,200 mg/day 1{,}000 - 1{,}200\text{ mg/day} 1 , 000 − 1 , 200 mg/day ): Clinical Rule: Do NOT restrict dietary calcium. Dietary calcium binds dietary oxalate within the gastrointestinal tract, forming an insoluble precipitate (calcium oxalate) that is excreted in feces. If dietary calcium is restricted, free unbound oxalate is absorbed across the intestinal mucosa into the bloodstream and cleared by the kidney, inducing hyperoxaluria , which dramatically accelerates stone formation.
Dietary Oxalate Restriction: Restrict high-oxalate foods: spinach, beets, rhubarb, Swiss chard, star fruit ( balimbing —which also contains deadly neurotoxins in renal failure), cocoa, nuts, black tea.
Vitamin C Moderation: Avoid high-dose ascorbic acid supplements ( > 500 mg/day > 500\text{ mg/day} > 500 mg/day ), as ascorbic acid is metabolized into oxalate.
Generous Hydration: Daily fluid intake ≥ 2.5 − 3.0 L/day \ge 2.5 - 3.0\text{ L/day} ≥ 2.5 − 3.0 L/day to ensure daily urine volume ≥ 2.0 − 2.5 L/day \ge 2.0 - 2.5\text{ L/day} ≥ 2.0 − 2.5 L/day and lower urinary solute concentration.
2. Uric Acid Stones (approx. 10% of calculi)
Pathophysiology: Occur when urinary pH is persistently acidic ( pH < 5.5 \text{pH} < 5.5 pH < 5.5 ), which precipitates insoluble un-ionized uric acid.
MNT: Urine alkalinization (titrate to urinary pH 6.5 − 7.0 \text{pH } 6.5 - 7.0 pH 6.5 − 7.0 ) using potassium citrate or an alkaline ash diet (rich in vegetables, fruits, and fruit juices; low in meat, fish, and grains). Restrict dietary purines (organ meats, anchovies, sardines, meat extracts, yeast) to lower uric acid excretion.